Pharmaceuticals, Biotechnology and Life Sciences
– Recent KVD900 Phase 2 Clinical Trial Results Statistically and Clinically Significant –
– IND Submitted for Oral Prophylactic HAE Treatment Candidate KVD824; Phase 2 Expected to Initiate in Q2 2021 –
– Following Upsized Public Offering, Funded to …
– Recent KVD900 Phase 2 Clinical Trial Results Statistically and Clinically Significant –
– IND Submitted for Oral Prophylactic HAE Treatment Candidate KVD824; Phase 2 Expected to Initiate in Q2 2021 –
– Following Upsized Public Offering, Funded to …
– Recent KVD900 Phase 2 Clinical Trial Results Statistically and Clinically Significant –
– IND Submitted for Oral Prophylactic HAE Treatment Candidate KVD824; Phase 2 Expected to Initiate in Q2 2021 –
– Following Upsized Public Offering, Funded to …
DUBLIN–(BUSINESS WIRE)–The “Clinical Laboratory Services – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.
The global market for Clinical Laboratory Services is projected to reach US$ 126.7 billi…
DUBLIN–(BUSINESS WIRE)–The “Clinical Laboratory Services – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.
The global market for Clinical Laboratory Services is projected to reach US$ 126.7 billi…
DUBLIN–(BUSINESS WIRE)–The “Clinical Laboratory Services – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.
The global market for Clinical Laboratory Services is projected to reach US$ 126.7 billi…
DUBLIN–(BUSINESS WIRE)–The “Global Specialty Pharmaceutical Partnering Terms and Agreements 2014-2021” report has been added to ResearchAndMarkets.com’s offering.
The Global Specialty Pharmaceutical Partnering Terms and Agreements 2014 to 2021 repor…
DUBLIN–(BUSINESS WIRE)–The “Global Specialty Pharmaceutical Partnering Terms and Agreements 2014-2021” report has been added to ResearchAndMarkets.com’s offering.
The Global Specialty Pharmaceutical Partnering Terms and Agreements 2014 to 2021 repor…
Presenting final 5 year immune response data from the Phase IIb clinical trial for recurring breast cancer
Planning completion of GP2 manufacturing in 2nd/3rd quarter of 2021
Presenting updated design for Phase III clinical trial that is planned …
DUBLIN–(BUSINESS WIRE)–The “Global Pediatrics Partnering 2010-2021: Deal Trends, Players and Financials” report has been added to ResearchAndMarkets.com’s offering.
Global Pediatrics Partnering 2010 to 2021 provides the full collection of Pediatrics…